These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10563454)

  • 1. Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment.
    Madsen AL; Karle A; Rubin P; Cortsen M; Andersen HS; Hemmingsen R
    Acta Psychiatr Scand; 1999 Nov; 100(5):367-74. PubMed ID: 10563454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients.
    Roiz-Santiáñez R; Ortiz-García de la Foz V; Ayesa-Arriola R; Tordesillas-Gutiérrez D; Jorge R; Varela-Gómez N; Suárez-Pinilla P; Córdova-Palomera A; Navasa-Melado JM; Crespo-Facorro B
    Psychol Med; 2015 Oct; 45(13):2861-71. PubMed ID: 26004991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT abnormalities in schizophrenia. A preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms.
    McCarley RW; Faux SF; Shenton M; LeMay M; Cane M; Ballinger R; Duffy FH
    Arch Gen Psychiatry; 1989 Aug; 46(8):698-708. PubMed ID: 2751404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests.
    Larøi F; Fannemel M; Rønneberg U; Flekkøy K; Opjordsmoen S; Dullerud R; Haakonsen M
    Psychiatry Res; 2000 Nov; 100(1):49-58. PubMed ID: 11090725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.
    Novak B; Milcinski M; Grmek M; Kocmur M
    Neuro Endocrinol Lett; 2005 Dec; 26(6):685-9. PubMed ID: 16380684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance.
    Falkai P; Schneider T; Greve B; Klieser E; Bogerts B
    J Neural Transm Gen Sect; 1995; 99(1-3):63-77. PubMed ID: 8579808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia.
    Scully PJ; Coakley G; Kinsella A; Waddington JL
    Psychol Med; 1997 Nov; 27(6):1303-10. PubMed ID: 9403902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
    Ho BC; Andreasen NC; Flaum M; Nopoulos P; Miller D
    Am J Psychiatry; 2000 May; 157(5):808-15. PubMed ID: 10784476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis.
    Malla AK; Mittal C; Lee M; Scholten DJ; Assis L; Norman RM
    J Psychiatry Neurosci; 2002 Sep; 27(5):350-8. PubMed ID: 12271790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia.
    Hoff AL; Sakuma M; Razi K; Heydebrand G; Csernansky JG; DeLisi LE
    Am J Psychiatry; 2000 Nov; 157(11):1824-8. PubMed ID: 11058480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive brain changes in children and adolescents with first-episode psychosis.
    Arango C; Rapado-Castro M; Reig S; Castro-Fornieles J; González-Pinto A; Otero S; Baeza I; Moreno C; Graell M; Janssen J; Parellada M; Moreno D; Bargalló N; Desco M
    Arch Gen Psychiatry; 2012 Jan; 69(1):16-26. PubMed ID: 22213785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia.
    Kasai K; Shenton ME; Salisbury DF; Hirayasu Y; Lee CU; Ciszewski AA; Yurgelun-Todd D; Kikinis R; Jolesz FA; McCarley RW
    Am J Psychiatry; 2003 Jan; 160(1):156-64. PubMed ID: 12505815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cortical anatomy and clozapine response in refractory schizophrenia.
    Honer WG; Smith GN; Lapointe JS; MacEwan GW; Kopala L; Altman S
    Neuropsychopharmacology; 1995 Aug; 13(1):85-7. PubMed ID: 8526974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates of cerebral ventricular enlargement in schizophrenia. Further evidence for frontal lobe disease.
    Klausner JD; Sweeney JA; Deck MD; Haas GL; Kelly AB
    J Nerv Ment Dis; 1992 Jul; 180(7):407-12. PubMed ID: 1624920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms and hypofrontality in chronic schizophrenia.
    Wolkin A; Sanfilipo M; Wolf AP; Angrist B; Brodie JD; Rotrosen J
    Arch Gen Psychiatry; 1992 Dec; 49(12):959-65. PubMed ID: 1360200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.
    Gogtay N; Sporn A; Clasen LS; Nugent TF; Greenstein D; Nicolson R; Giedd JN; Lenane M; Gochman P; Evans A; Rapoport JL
    Arch Gen Psychiatry; 2004 Jan; 61(1):17-22. PubMed ID: 14706940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.